Adenovirus VAI RNA is required for efficient translation of viral mRNAs at late times after infection
about
The 58,000-dalton cellular inhibitor of the interferon-induced double-stranded RNA-activated protein kinase (PKR) is a member of the tetratricopeptide repeat family of proteinsThe cDNA sequences of the sea urchin U7 small nuclear RNA suggest specific contacts between histone mRNA precursor and U7 RNA during RNA processingEAP, a highly conserved cellular protein associated with Epstein-Barr virus small RNAs (EBERs)Distinctive sequence organization and functional programming of an Alu repeat promoterAdenovirus VA RNAI: a positive regulator of mRNA translationSecond-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectorsAdenovirus VAI-RNA regulates gene expression by controlling stability of ribosome-bound RNAsThe Ro small cytoplasmic ribonucleoproteins: identification of the antigenic protein and its binding site on the Ro RNAsSequence-specific interference by small RNAs derived from adenovirus VAI RNACloning and expression of the rat interleukin-3 geneEfficient generation of double heterologous promoter controlled oncolytic adenovirus vectors by a single homologous recombination step in Escherichia coliMolecular mechanisms of Dicer: endonuclease and enzymatic activity.Analysis of synthesis, stability, phosphorylation, and interacting polypeptides of the 34-kilodalton product of open reading frame 6 of the early region 4 protein of human adenovirus type 5Immune evasion by adenoviruses.The tripartite leader sequence of subgroup C adenovirus major late mRNAs can increase the efficiency of mRNA export.Adenovirus induction of an interferon-regulatory factor during entry into the late phase of infection.Adenovirus inhibition of cellular protein synthesis is prevented by the drug 2-aminopurine.Tumor-specific, replication-competent adenovirus vectors overexpressing the adenovirus death proteinSuppression of the translation defect phenotype specific for a virus-associated RNA-deficient adenovirus mutant in monkey cells by simian virus 40.Characterization of a low-molecular-weight virus-associated (VA) RNA encoded by simian adenovirus type 7 which functionally can substitute for adenovirus type 5 VA RNAIFunctional analysis of the adenovirus type 5 DNA-binding protein: site-directed mutants which are defective for adeno-associated virus helper activity.Role of the apical stem in maintaining the structure and function of adenovirus virus-associated RNA.Characterization of the SS-B (La) antigen in adenovirus-infected and uninfected HeLa cells.Translational control of viral gene expression in eukaryotesModeling adenovirus latency in human lymphocyte cell lines.Small RNA sequence analysis of adenovirus VA RNA-derived miRNAs reveals an unexpected serotype-specific difference in structure and abundanceRNA polymerase III transcription: its control by tumor suppressors and its deregulation by transforming agents.Tipping the balance: antagonism of PKR kinase and ADAR1 deaminase functions by virus gene products.Complementation of adenovirus virus-associated RNA I gene deletion by expression of a mutant eukaryotic translation initiation factor.Genetic identification of adenovirus type 5 genes that influence viral spread.RNA binding and intramolecular interactions modulate the regulation of gene expression by nuclear factor 110.Noncoding RNPs of viral originA heat shock-induced, polymerase III-transcribed RNA selectively associates with polysomal ribosomes in Tetrahymena thermophilaUnabated adenovirus replication following activation of the cGAS/STING-dependent antiviral response in human cells.Development of resistance to RNAi in mammalian cellsViral and cellular microRNAs as determinants of viral pathogenesis and immunity.Structural features of adenovirus 2 virus-associated RNA required for binding to the protein kinase DAI.Protection of human endothelial cells from oxidant injury by adenovirus-mediated transfer of the human catalase cDNAIdentification of RISC-associated adenoviral microRNAs, a subset of their direct targets, and global changes in the targetome upon lytic adenovirus 5 infection.Nucleotide sequence of small polyadenylated B2 RNA
P2860
Q24305192-7CF60725-ACD2-4E25-9F95-BD34271270FFQ24555637-E0056563-F83B-4B82-B003-2A3DC3465AA8Q24561541-431C0530-2F96-43E5-83C1-06764E6F3362Q24607877-18B0151E-0948-4187-A963-0F5AFDDD3004Q24610606-6B2969D1-EFF2-4E8F-AEB0-816C8FA7010CQ24682739-DB3F29B9-03E0-43B8-A3CE-95806FA80C9EQ28259761-C2E399AC-D452-4EF1-81A2-E00B1728F35CQ28262911-7DC7E8E3-D257-4853-9DED-A7D8E4092E85Q28296813-921B34D9-4A7D-452A-AC9B-4F4F294B6570Q28579802-D4BB1A81-66FA-4611-AC8F-B9687623F6BFQ33252754-FD886160-77FE-4C63-992A-4C252E8CD6BCQ33634981-9EC9E5AD-2668-4E4A-872C-82EF0E444A99Q33641023-6BEBFCC3-FCAE-48C7-8453-3099B5111D88Q33683353-AD3D7898-63FE-405E-BA62-84B90B8699C6Q33781940-0EE85CEB-E349-42E0-A999-0F3DE8BADAFBQ33785452-109D9A16-7632-4F54-B1B8-C69C1F3A935EQ33792872-86800B8D-FBA9-45A8-8631-6F0E5D2D2AE4Q33807026-F8E6872A-A0B9-4302-AA28-0A41E6FED0AFQ33926830-9E4042A7-C93E-46CE-BAAD-F693DD4450E0Q33928622-9A2FDFC8-CB74-4091-BC71-83958A776A0FQ33928717-7AA6092E-E6BE-4FC0-90FD-C675CDF84DDEQ33932538-842DB609-126D-4343-AF5C-3967141A4530Q33933837-03DD885F-0F9B-4794-BBA4-74FD0EB8E329Q33935121-7625A096-050C-4086-806F-FD372317DD70Q34055402-CAA20200-77BA-45C7-84FB-B588F3B512BBQ34075721-5295DDF8-0E1C-4CAC-99CF-93B24117D018Q34093164-89AD997C-1596-4A07-8F8D-39F0755315BEQ34208420-29A0887C-D11E-4C48-B503-494FAE6C1DE8Q34322100-7751CF7D-8B0A-4A4C-AE24-694733A06531Q34353556-6951269E-DEEA-4043-9031-051A18E496E9Q34365094-CB6453F1-C06F-4FD0-A410-10D4CCE2E8BBQ34578041-27C8CB2B-87A3-42BD-8670-6BF1DBA7507CQ34588167-5AF8786C-E6BA-4940-9918-56C64F7511C3Q34594959-004A0B0C-FC89-4E89-A410-DAD6CF918914Q34619725-3A3EB233-DCEC-4994-9A52-3CCD0E65D5A3Q34815231-6128A91C-3570-4246-A80E-CBC83FCDB39CQ34888248-0F40C59D-5B70-46A3-A409-415F5E24877FQ34978455-E373FEBD-8E32-4269-956F-30FACFAEBB33Q34991408-5C36E95A-D377-47CF-809B-F95156D85801Q35023712-F9F54E51-9932-45BB-A092-1D3FD854A5F2
P2860
Adenovirus VAI RNA is required for efficient translation of viral mRNAs at late times after infection
description
1982 nî lūn-bûn
@nan
1982 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1982 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1982年の論文
@ja
1982年論文
@yue
1982年論文
@zh-hant
1982年論文
@zh-hk
1982年論文
@zh-mo
1982年論文
@zh-tw
1982年论文
@wuu
name
Adenovirus VAI RNA is required ...... at late times after infection
@ast
Adenovirus VAI RNA is required ...... at late times after infection
@en
Adenovirus VAI RNA is required ...... at late times after infection
@nl
type
label
Adenovirus VAI RNA is required ...... at late times after infection
@ast
Adenovirus VAI RNA is required ...... at late times after infection
@en
Adenovirus VAI RNA is required ...... at late times after infection
@nl
prefLabel
Adenovirus VAI RNA is required ...... at late times after infection
@ast
Adenovirus VAI RNA is required ...... at late times after infection
@en
Adenovirus VAI RNA is required ...... at late times after infection
@nl
P2093
P3181
P1433
P1476
Adenovirus VAI RNA is required ...... at late times after infection
@en
P2093
B Thimmappaya
C Weinberger
R J Schneider
P304
P3181
P356
10.1016/0092-8674(82)90310-5
P407
P433
P577
1982-12-01T00:00:00Z